Bayer: all 1,694 studies
Page 16 of 17. Open to participants first (61), then studies with results posted, then the rest; newest registration first within each.
- Study Evaluating the Efficacy of Nifedipine GITS - Telmisartan Combination in Blood Pressure Control.CompletedNCT00750113Phase 4
- Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the SkeletonCompletedNCT00748046Phase 1
- Inhibition of Ovulation, Patch, Ethinylestradiol and GestodeneTerminatedNCT00729404Phase 2
- A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired PneumoniaCompletedNCT00717561Phase 3
- Adalat XL vs Diltiazem on Proteinuria and Blood Pressure in Hypertensive Diabetic PatientsWithdrawnNCT00713011Phase 3
- Nebido Versus Placebo in Elderly Men With Typical Symptoms of Late Onset Hypogonadism Over a Period of 54 WeeksWithdrawnNCT00710827Phase 4
- Mirena Efficiency and Tolerability During the First Year of UseCompletedNCT00696202Phase 4
- Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH)CompletedNCT00694850Phase 2
- Fast & Fed Pharmacokinetic (PK) StudyCompletedNCT00692016Phase 1
- Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.CompletedNCT00683865Phase 3
- Study Evaluation the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction for 10 WeeksCompletedNCT00682019Phase 3
- Evaluation of the Safety and Efficacy of Vardenafil in Subjects With Erectile DysfunctionCompletedNCT00681772Phase 4
- Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Patients With Brain MetastasisCompletedNCT00681551Phase 3
- Interaction Study in Patients With Pulmonary Hypertension and Stable Treatment of Sildenafil 20 mg TIDCompletedNCT00680654Phase 1
- BAY38-9456 - Pivotal Trial for Diabetes PatientCompletedNCT00678704Phase 3
- Cipro® XR in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract InfectionsCompletedNCT00676533Phase 4
- Study to Investigate the Effect of Missed Pills on Follicular Development in Two Application Regimens of SH T 00186 DCompletedNCT00673686Phase 2
- Effects of Adalat LA and Coracten on Drug Levels, Blood Pressure, and Heart Rate in Fed Patients With HypertensionCompletedNCT00672113Phase 4
- BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection ProphylaxisCompletedNCT00670215Phase 3
- Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract InfectionsCompletedNCT00669994Phase 4
- Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With AveloxCompletedNCT00668304Phase 4
- Assessment of Vardenafil in Patients With Erectile Dysfunction in AsiaCompletedNCT00668135Phase 4
- Efficacy and Safety of CIPRO XR Versus CIPRO IR in Patients With Complicated Urinary Tract InfectionsCompletedNCT00668122Phase 3
- Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or HyperlipidemiaCompletedNCT00668109Phase 3
- A Randomised Study of Levitra to Treat Men With Erections Problems and Previously Untreated With Similar Therapy.CompletedNCT00668096Phase 4
- BAY38-9456 (Vardenafil HCL Tablet) in ED Treatment for China Registration.CompletedNCT00668057Phase 3
- Ciprofloxacin on Burned PatientsCompletedNCT00668044Phase 3
- Effect of Aprotinin on Transfusion Requirements and Blood Loss in Patients Undergoing Elective Primary Total Hip ReplacementCompletedNCT00668031Phase 3
- Assess Efficacy of Vardenafil 10mg in Erectile Dysfunction Within Intake of 6 HoursCompletedNCT00668018Phase 3
- Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction and HypertensionCompletedNCT00668005Phase 3
- Evaluating the Efficacy of Vardenafil in Subjects With Erectile Dysfunction (ED) Administered 12, 18 or 24 Hours Prior to IntercourseCompletedNCT00667979Phase 4
- Assess Efficacy in Subjects With Traumatic Spinal Cord InjuryCompletedNCT00667966Phase 4
- PK in Pts With HRPC & Skeletal MetastesCompletedNCT00667537Phase 1
- BAY88-8223, Does Response Study in HRPC PatientsCompletedNCT00667199Phase 2
- Vardenafil in TinnitusCompletedNCT00666809Phase 2
- A Study to Investigate the Time to Onset of Action of 10 mg and 20 mg of Vardenafil Compared to Placebo in Males With Erectile DysfunctionCompletedNCT00665496Phase 3
- Investigate the Responsiveness of the Erectile Quality Scale to Vardenafil Flexible Dose vs Placebo in Males With Erectile Dysfunction (ED)CompletedNCT00665340Phase 4
- Avelox for Treatment of Elderly Patients With Community Acquired PneumoniaCompletedNCT00665327Phase 4
- BAY38-9456, 5/10/20mg, vs.Placebo in Erectile DysfunctionCompletedNCT00665054Phase 4
- Evaluation of LEVITRA to Advance the Treatment of Erectile DysfunctionCompletedNCT00664833Phase 4
- Assessing Efficacy and Safety of Flexible Dosing With Vardenafil in Subjects With Erectile Dysfunction and HyperlipidemiaCompletedNCT00663845Phase 4
- A Phase IV Study of Cipro XR in Uncomplicated UTICompletedNCT00663806Phase 4
- Sorafenib Gastric Cancer Asian Phase I StudyCompletedNCT00663741Phase 1
- Assessment of Duration of Erection With Vardenafil 10 mgCompletedNCT00663728Phase 4
- Levitra® - Real Life Safety and Efficacy of LevitraCompletedNCT00663598Phase 4
- Evaluating the Efficacy Vardenafil 10 mg vs Tadalafil 10 mg in in Subjects With Erectile Dysfunction (ED)CompletedNCT00663130Phase 4
- Evaluating of the Efficacy and Safety of Vardenafil in Subjects With Erectile DysfunctionCompletedNCT00662441Phase 4
- A Double-blind "Preferred" Vardenafil Dose Study of QoL and Functional Outcomes in Males With Erectile DysfunctionCompletedNCT00661700Phase 3
- Assessment of Efficacy of Vardenafil, Influence on Self-esteem and Self-confidence in Subjects With Erectile DysfunctionCompletedNCT00661596Phase 3
- BAY43-9006 Phase II Study for Renal Cell CarcinomaCompletedNCT00661375Phase 2
- Study Evaluating the Efficacy, Safety, and Reliability of VardenafilCompletedNCT00661297Phase 3
- Depression Related Improvement With Vardenafil for Erectile ResponseCompletedNCT00661219Phase 3
- Open Label Phase II Study of BAY 43-9006 in Chronic Myelogenous Leukemia (CML) Patients Resistant to GleevecCompletedNCT00661180Phase 2
- To Investigate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction.CompletedNCT00661115Phase 3
- Evaluation of Efficacy and Safety of Vardenafil in Patients With Erectile Dysfunction and Type 1 DiabetesCompletedNCT00660998Phase 4
- Study Evaluating the Efficacy and Safety of Flexible-dose Vardenafil in Subjects With Erectile DysfunctionCompletedNCT00658177Phase 3
- Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic HyperplasiaCompletedNCT00657839Phase 2
- Efficacy and Safety of Vardenafil in Men With Erectile DysfunctionCompletedNCT00657644Phase 3
- Extension Program for Bay 43-9006CompletedNCT00657254Phase 2
- Study to Investigate the Efficacy and Safety of Vardenafil Flexible Dose Versus Placebo in Males With Erectile DysfunctionCompletedNCT00657033Phase 3
- Evaluate Safety and Efficacy of an Oral Contraceptive (OC) Preparation Versus Placebo for 6 Treatment Cycles in Women With Moderate AcneCompletedNCT00656981Phase 3
- Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic BronchitisCompletedNCT00656747Phase 4
- Placebo-controlled Study Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile DysfunctionCompletedNCT00656188Phase 2/3
- Assess the Effect of Daily Treatment of Vardenafil 20mg or Sildenafil 100mg and Placebo on Sperm FunctionCompletedNCT00655590Phase 4
- A Study to Assess the Efficacy and Safety of Vardenafil in the Treatment of Male Patients With Erectile DysfunctionCompletedNCT00654914Phase 3
- Evaluating the Efficacy and Safety of Vardenafil in Patients Erectile Dysfunction Solely Secondary to Spinal Cord InjuryCompletedNCT00654680Phase 3
- Cycle Control and Safety of E2-DRSPCompletedNCT00653614Phase 2
- Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance AngiographyCompletedNCT00652418Phase 2
- BAY38-9456 - Supportive Trial for Spinal InjuryCompletedNCT00652262Phase 3
- Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy WomenCompletedNCT00651846Phase 4
- Treatment of Vasomotor Symptoms in Korean Post Menopausal WomenCompletedNCT00651599Phase 3
- Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.CompletedNCT00651469Phase 3
- A Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a Period of 3 Treatment CyclesCompletedNCT00631124Phase 2
- Pharmacokinetics and Safety of a Single Intravenous Infusion of BAY 79-4980CompletedNCT00629837Phase 1
- Yasmin 20 Cycle Control - Yasmin 20 Versus Mercilon in Healthy Female VolunteersCompletedNCT00624130Phase 3
- Mechanistic Evaluation on Sorafenib Induced Hypophosphatemia.TerminatedNCT00622479Phase 1
- Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia ATerminatedNCT00621673Phase 4
- Aprotinin US Special Access ProtocolNo longer availableNCT00611845
- Phase 1 Dose-escalation PK/PD Trial in Advanced Cancer PatientsCompletedNCT00610194Phase 1
- Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid TumorsCompletedNCT00606125Phase 1
- BAY14-2222 Continuous Infusion in SurgeriesCompletedNCT00606060Phase 3
- SH T00186 in the Treatment of Primary DysmenorrheaCompletedNCT00569244Phase 3
- Study to Investigate the Effect of the A1 Agonist Capadenoson on Ventricular HR in Patients With Persistent or Permanent Atrial Fibrillation.CompletedNCT00568945Phase 2
- A Clinical Study in Children and Adolescents With Mild to Moderate Atopic DermatitisCompletedNCT00568412Phase 4
- Efficacy and Safety of Oral Dehydroepiandrosterone as a Concomitant Therapy to Oral Contraceptives in Women Complaining of Reduced LibidoCompletedNCT00566384Phase 2
- Single Dose Escalation Study in Patients With Chronic Heart FailureCompletedNCT00565565Phase 1
- Phase I Study of Sorafenib Dosed Continuously With Cyclophosphamide and DoxorubicinCompletedNCT00562913Phase 1
- Sorafenib/Docetaxel Dose Escalation TrialCompletedNCT00562523Phase 1
- A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic RhinitisCompletedNCT00561717Phase 4
- Placebo Controlled, Randomized, Double-blind, Multi-center Study to Investigate the Efficacy and Tolerability of BAY58-2667TerminatedNCT00559650Phase 2
- ZK 230211 in Postmenopausal Woman With Metastatic Breast CancerCompletedNCT00555919Phase 2
- BENEFIT Extension StudyCompletedNCT00544037
- ZK283197 for Treatment of Vasomotor SymptomsCompletedNCT00537836Phase 2
- Capadenoson in Angina PectorisWithdrawnNCT00518921Phase 2
- HR-QoL and Sexuality in Mirena Inserted Contraception UsersCompletedNCT00498784Phase 4
- An Open-Label, Non-Comparative, Phase III Study of the Raf-Kinase Inhibitor BAY 43-9006 as a Subsequent to First-Line Therapy in Patients With Advanced Renal Cell CarcinomaCompletedNCT00492986Phase 3
- Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil vs Vardenafil PRN vs Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving EDCompletedNCT00492635Phase 3
- Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in Patients With Hand EczemaCompletedNCT00488241Phase 4
- Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common UropathogensCompletedNCT00481689Phase 4
- Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic BronchitisCompletedNCT00473460Phase 3